http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe. http://medicalxpress.com/news/2012-11-glaxosmithkline-q3-net-profits.html Other Thu, 01 Nov 2012 05:03:48 EST news270965021 (AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced. http://medicalxpress.com/news/2012-10-japanese-firm-montana-pharmaceutical-company.html Medications Fri, 05 Oct 2012 12:51:34 EST news268660282 (AP)—Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care. http://medicalxpress.com/news/2012-09-valeant-26b-medicis.html Medications Mon, 03 Sep 2012 15:56:56 EST news265906603 German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients. http://medicalxpress.com/news/2012-07-merck-kgaa-setback-cancer-drug.html Cancer Thu, 05 Jul 2012 08:00:31 EST news260694026 An international treaty is a promising tool for improving the coherence, fairness, efficiency, and sustainability of the global health research and development system according to international experts writing in this week's PLoS Medicine. http://medicalxpress.com/news/2012-05-international-treaty-medical-worldwide.html Medical research Tue, 15 May 2012 17:00:12 EST news256312423 The expert working group advising WHO on research and development has recommended the May 2012 World Health Assembly adopt an international convention on research and development (R&D) that will bind member states to action and catalyze new knowledge for diseases that primarily affect the global poor but for which patents provide insufficient market incentives. http://medicalxpress.com/news/2012-05-world-health-international-convention-global.html Health Tue, 15 May 2012 17:00:01 EST news256312461 The prospect of deep cuts in the federal budget threatens to reverse the dramatic progress of a bipartisan US commitment to defeat neglected diseases in developing countries, according to a new report released today by the Global Health Technologies Coalition (GHTC). Federal investments in global health research and development (R&D) programs that span multiple agencies have helped nurture an array of new vaccines, medicines, diagnostics, and other health products needed to combat diseases like HIV/AIDS, malaria, tuberculosis (TB), and childhood killers like pneumonia and diarrheal diseases. Despite these advances, President Obama's budget request for 2013 calls for several decreases for global health when compared with last year's levels. Several global health R&D programs at US agencies also saw drastic funding cuts. http://medicalxpress.com/news/2012-02-setbacks-global-health-due-current.html Health Tue, 28 Feb 2012 12:57:56 EST news249656262 The study identifies the respective contributions of direct and indirect government support in research and development of new pharmaceutical drugs. http://medicalxpress.com/news/2011-12-respective-roles-private-sectors-pharmaceutical.html Medications Thu, 15 Dec 2011 13:09:13 EST news243176934 Nearly three-quarters (74%) of Georgia residents think spending money on research to improve health globally is important for economic development in Georgia, according to a new statewide poll commissioned by Research!America. http://medicalxpress.com/news/2011-06-georgia-residents-investment-global-health.html Health Wed, 29 Jun 2011 11:22:07 EST news228565316